ADULT ACUTE BASOPHILIC LEUKEMIA

Clinical trials for ADULT ACUTE BASOPHILIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new ADULT ACUTE BASOPHILIC LEUKEMIA trials appear

Sign up with your email to follow new studies for ADULT ACUTE BASOPHILIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New strategy aims to make leukemia cells more vulnerable to chemo

Disease control Ongoing

This study is testing whether adding a drug called decitabine before standard chemotherapy helps treat acute myeloid leukemia (AML) more effectively. The goal is to see if decitabine can 'prime' or sensitize the cancer cells, making them easier for the chemotherapy drugs to kill.…

Matched conditions: ADULT ACUTE BASOPHILIC LEUKEMIA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 11, 2026 14:54 UTC

ADULT ACUTE BASOPHILIC LEUKEMIA

Get alerted when new ADULT ACUTE BASOPHILIC LEUKEMIA trials appear

New strategy aims to make leukemia cells more vulnerable to chemo